PMV PHARMACEUTICALS INC (PMVP)
US69353Y1038 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 37.71M | 108.30M | 172.50M | 361.40M | 73.30M | |||
| Marketable Securities | 165.35M | 132.80M | 124.70M | 0.00 | 28.20M | |||
| Other Current Assets | 4.35M | 5.90M | 4.10M | 3.30M | 600.00K | |||
| Total Current Assets | 207.41M | 247.00M | 301.30M | 364.80M | 102.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 19.05M | 20.50M | 13.20M | 600.00K | 700.00K | |||
| Investments And Advances | 25.50M | 2.50M | 16.90M | N/A | N/A | |||
| Other Non-Current Assets | 190.00K | 300.00K | 200.00K | 200.00K | 200.00K | |||
| Total Non-Current Assets | 44.74M | 23.30M | 30.30M | 700.00K | 900.00K | |||
| TOTAL ASSETS | 252.15M | 270.30M | 331.60M | 365.50M | 103.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 10.79M | 7.80M | 9.00M | 4.80M | 1.70M | |||
| Accounts Payable | 3.24M | 3.00M | 3.20M | 1.60M | 2.80M | |||
| Total Current Liabilities | 14.03M | 10.80M | 12.20M | 6.40M | 4.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 12.43M | 13.40M | 10.80M | 0.00 | 100.00K | |||
| Total Non-Current Liabilities | 12.43M | 13.50M | 10.80M | 0.00 | 100.00K | |||
| TOTAL LIABILITIES | 26.46M | 24.30M | 23.00M | 6.40M | 4.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -310.00M | -241.00M | -167.70M | -109.90M | -75.40M | |||
| Additional Paid In Capital | 535.47M | 487.50M | 476.40M | 469.00M | 5.00M | |||
| Common Shares | 510.00 | 0.00 | 0.00 | 0.00 | 168.90M | |||
| Other Shareholders' Equity | -510.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Shares Outstanding | 51.45M | 45.80M | 45.40M | 44.80M | 43.00M | |||
| Tangible Book Value per Share | 4.39 | 5.37 | 6.80 | 8.02 | -1.64 | |||
| Total Shareholders' Equity | 225.69M | 246.00M | 308.60M | 359.10M | 98.50M | |||
| TOTAL LIABILITIES AND EQUITY | 252.15M | 270.30M | 331.60M | 365.50M | 103.00M | |||
| Statistics | ||||||||
| Current Ratio | 14.78 | 22.87 | 24.70 | 57.00 | 22.69 | |||
| Return On Assets (ROA) | -27.35% | -27.13% | -17.45% | -9.42% | -24.61% | |||
| Return On Equity (ROE) | -30.56% | -29.80% | -18.75% | -9.59% | -25.74% | |||
All data in USD